Blueshift Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Blueshift Asset Management's HALO Position: Q2 2026 in Review
Blueshift Asset Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 8,269 shares — an estimated $534K sold.
Blueshift Asset Management first reported a position in HALO in Q4 2019 and held it in 6 quarters. The position peaked at $781K in Q3 2021. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Blueshift Asset Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
- Blueshift Asset Management sold 8,269 Halozyme shares in Q2 2026, an estimated $534K.
- Blueshift Asset Management first reported a position in Halozyme in Q4 2019 and held it in 6 quarters.
- Blueshift Asset Management's Halozyme position peaked at $781K in Q3 2021.
- 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.